Dissolving polymer stent shows promise

12/11/2006 | BBC

A 30-day study of 30 patients implanted with the BVS stent, made from a bioabsorbable polymer that turns into lactic acid over a period of two to three years, contains "perfect" data and no adverse effects. Researchers hope the stent will reduce the risk of late-stent thrombosis and will allow for clearer imaging. Six-month data from the same 30 patients will be released in March.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC